Charles River Laboratories International, Inc. (CRL)

CRL Stock Forecast

Stock Price Forecast

The 15 analysts that cover CRL stock have a consensus rating of "Hold" and an average price target of $186.38, which forecasts a 24.25% increase in the stock price over the next year. The lowest target is $140 and the highest is $250.

Price Target: $186.38 (+24.25%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$140	$186.38	$182	$250
Change	-6.67%	+24.25%	+21.33%	+66.66%

* Price targets were last updated on May 23, 2025.

Analyst Ratings

The average analyst rating for CRL stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	2	1	1	2	2
Buy	0	0	0	0	0	0
Hold	12	11	13	13	13	13
Sell	0	0	0	0	0	0
Strong Sell	2	2	1	1	0	0
Total	16	15	15	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jamie Clark Redburn Atlantic	Redburn Atlantic	Hold → Strong Buy Upgrades $188 → $182	Hold → Strong Buy	Upgrades	$188 → $182	+21.33%	May 23, 2025
Luke Sergott Barclays	Barclays	Hold Maintains $145 → $155	Hold	Maintains	$145 → $155	+3.33%	May 8, 2025
Eric Coldwell Baird	Baird	Hold Maintains $118 → $140	Hold	Maintains	$118 → $140	-6.67%	May 8, 2025
Luke Sergott Barclays	Barclays	Hold Maintains $160 → $145	Hold	Maintains	$160 → $145	-3.34%	Apr 10, 2025
Ann Hynes Mizuho	Mizuho	Hold Maintains $175 → $155	Hold	Maintains	$175 → $155	+3.33%	Apr 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.94B

Decreased by -2.81%

from 4.05B

Revenue Next Year

4.03B

Increased by 2.49%

from 3.94B

EPS This Year

9.69

Increased by 4,746.14%

from 0.20

EPS Next Year

10.36

Increased by 6.90%

from 9.69

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 26, 2020	Dec 25, 2021	Dec 31, 2022	Dec 30, 2023	Dec 28, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.92B	3.54B	3.98B	4.13B	4.05B	3.94B	4.03B	4.24B
Revenue Growth	11.55%	21.08%	12.31%	3.86%	-1.92%	-2.81%	2.49%	4.98%
EPS	7.20	7.60	9.48	9.22	0.20	9.69	10.36	11.29
EPS Growth	42.01%	5.56%	24.74%	-2.74%	-97.83%	4,746.14%	6.90%	8.98%
Forward PE	-	-	-	-	-	15.48	14.48	13.28
No. Analysts	-	-	-	-	-	21	21	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	4.2B	4.3B	4.8B
Avg	3.9B	4.0B	4.2B
Low	3.8B	3.8B	3.9B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	3.1%	9.3%	18.7%
Avg	-2.8%	2.5%	5.0%
Low	-6.8%	-4.7%	-4.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	10.29	11.48	12.75
Avg	9.69	10.36	11.29
Low	9.11	8.89	10.05

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	5,045.0%	18.5%	23.0%
Avg	4,746.1%	6.9%	9.0%
Low	4,457.0%	-8.3%	-3.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.